Home » AKORN, INC. ANNOUNCES RECEIPT OF REQUEST FOR PROPOSAL FOR CALCIUM-DTPA AND ZINC-DTPA
AKORN, INC. ANNOUNCES RECEIPT OF REQUEST FOR PROPOSAL FOR CALCIUM-DTPA AND ZINC-DTPA
Akorn, Inc. today announced that it has received a written RFP titled "Acquisition of Ca-DTPA and Zn-DTPA to Support a Public Health Emergency Response to a Radiological Nuclear Event" from the Department of Health and Human Services (HHS). The initial order quantities for each antidote product are 360,000 units of Ca-DTPA and 90,000 units of Zn-DTPA. The RFP also contains an option that may be exercised by the U.S. Government during a five-year period to purchase an additional one million units of DTPA.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1074901XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May